Skip to content

    WoMMen Trekking Peru: An Adventure to Support Myeloma Research With Gurbakhash Kaur, MD

    Expert Perspectives · Keira Smith · 2024-07-15

    This week, eight multiple myeloma women physicians (WoMMen) are embarking on a 30-mile hike through Ausangate Mountain in the Andes Mountain Range in Peru, with the goal of raising money for myeloma research and spreading awareness of the trials and tribulations that their patients face as they navigate their multiple myeloma mountain. Right before leaving for the airport, Dr. Gurbakhash Kaur, one of the team members and an OncData Editorial Board member, took a moment to share her excitement about the trek and tell us more about it, including:

    • Her fellow WoMMen Trekking Peru team members: Dr. Tanya Wildes of the University of Nebraska Medical Center, Dr. Urvi Shah of Memorial Sloan Kettering Cancer Center, Dr. Annette Hay of Queen’s University, Dr. Meera Mohan of the Medical College of Wisconsin, Dr. Monique Hartley-Brown of Dana-Farber Cancer Institute, Dr. Sarah Ryan of Queen’s University, and Dr. Attaya Suvannasankha of Indiana University School of Medicine
    • How the idea for the trek came about and their inspiration for embarking on it
    • The details of the hike and how they’ve been training for the high altitudes
    • What she’s most looking forward to on the adventure
    • The four organizations they’re raising money for—Multiple Myeloma Research Foundation, International Myeloma Foundation, Myeloma Canada, and HealthTree Foundation for Multiple Myeloma—and the goal of raising a total of $40,000 for multiple myeloma research
    • How you can show your support and donate to the cause

    Scan the QR codes or click the links below to donate and support each organization!

    About Dr. Kaur

    Gurbakhash Kaur, MD, is an Assistant Professor of Medicine in the Department of Internal Medicine at the University of Texas Southwestern Medical Center and Harold C. Simmons Comprehensive Cancer Center. She specializes in the treatment of patients with multiple myeloma, AL amyloidosis, and other plasma cell disorders, including the use of CAR T-cell therapy, immunotherapy, and stem cell transplantation. She actively participates in clinical trials investigating novel therapeutic options and quality-of-life improvements for patients with multiple myeloma.